Skip to main content

Proactive news headlines including Twitter, Elon Musk, BioSig, Starton Therapeutics and Irwin Naturals

New York , May 23, 2022 (GLOBE NEWSWIRE) — Proactive, provider of real-time news and video interviews on growth companies listed in the US and Canada, has covered the following companies:

  • BioSig maintains ‘Outperform’ rating from Noble Capital as “stronger commercialization efforts” underway for its PURE EP system click here
  • Pfizer/BioNTech say third vaccine dose is 80% effective against Omicron in kids 5 and younger click here
  • Musk suggests he wants a discount on his Twitter bid proportionate to number of spam bots  click here
  • Starton Therapeutics wins approval to proceed with final dose escalation in Phase 1 clinical study evaluating STAR-LLD  click here
  • TraceSafe announces record year in 2021 with annual revenue of US$13M  click here
  • Irwin Naturals completes acquisition of KHC Capital Group  click here

 

About Proactive

 

Proactive is a unique tech-enabled platform providing companies globally with a comprehensive investor engagement solution across their business lifecycle.

With six offices on three continents, Proactive works with innovative growth companies quoted on the world’s major stock exchanges, helping executives to engage intelligently with investors.

In 2020, Proactive featured in 809 million search results, our content was viewed over 165 million times and our readers spent over 10 million hours on our websites. Proactive has produced over 300,000 articles and 20,000 executive interviews since it was established in 2006.

For more information on how Proactive can help you make a difference, email us at action@proactiveinvestors.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.